DREAM and Chronic Arthritic Pain
Author Information
Author(s): Nataša Reisch, Andreas Engler, André Aeschlimann, Beat R. Simmen, Beat A. Michel, Renate E. Gay, Steffen Gay, Haiko Sprott
Primary Institution: University Hospital Zurich
Hypothesis
Does DREAM play a role in the regulation of pdyn expression in chronic pain patients?
Conclusion
DREAM does not qualify as a target for peripheral pain management in osteoarthritis patients.
Supporting Evidence
- DREAM mRNA expression was significantly reduced in OA patients with chronic pain.
- Inhibiting DREAM expression did not lead to significant changes in pdyn and c-fos expression.
- DREAM was detected on the mRNA level in both OA SFLCs and PBMCs.
Takeaway
DREAM is a protein that might help with pain, but in people with arthritis, it doesn't seem to work as we hoped.
Methodology
The study measured DREAM expression in synovial fibroblast-like cells and peripheral blood mononuclear cells using real-time PCR and siRNA.
Limitations
The study did not detect pdyn expression in PBMCs, and the role of DREAM in pain management remains unclear.
Participant Demographics
53 OA patients (23 females, 30 males) and 26 healthy controls.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website